{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:04:00Z","timestamp":1759773840664},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Prof. Dr. Max Clo\u00ebtta foundation, Zurich, Switzerland and the Uniscientia foundation, Vaduz, Principality of Liechtenstein","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12954-015-0090-x","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T18:19:03Z","timestamp":1452190743000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study"],"prefix":"10.1186","volume":"13","author":[{"given":"Michael","family":"Liebrenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Buadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Therese","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Caflisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"3","key":"90_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","volume":"18","author":"H Ashton","year":"2005","unstructured":"Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005;18(3):249\u201355. doi: 10.1097\/01.yco.0000165594.60434.84 .","journal-title":"Curr Opin Psychiatry"},{"issue":"Suppl 2","key":"90_CR2","first-page":"28","volume":"66","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66 Suppl 2:28\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"90_CR3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1360-0443.2010.02933.x","volume":"105","author":"M Liebrenz","year":"2010","unstructured":"Liebrenz M, Boesch L, Stohler R, Caflisch C. Agonist substitution\u2014a treatment alternative for high-dose benzodiazepine-dependent patients? Addiction (Abingdon, England). 2010;105(11):1870\u20134. doi: 10.1111\/j.1360-0443.2010.02933.x .","journal-title":"Addiction (Abingdon, England)"},{"issue":"11","key":"90_CR4","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1360-0443.2010.03087.x","volume":"105","author":"M Soyka","year":"2010","unstructured":"Soyka M. To substitute or not substitute\u2014optimal tactics for the management of benzodiazepine dependence. Addiction (Abingdon, England). 2010;105(11):1876\u20137.","journal-title":"Addiction (Abingdon, England)"},{"issue":"11","key":"90_CR5","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1360-0443.2010.03067.x","volume":"105","author":"P Tyrer","year":"2010","unstructured":"Tyrer P. Benzodiazepine substitution for dependent patients\u2014going with the flow. Addiction (Abingdon, England). 2010;105(11):1875\u20136.","journal-title":"Addiction (Abingdon, England)"},{"key":"90_CR6","doi-asserted-by":"crossref","unstructured":"Baandrup L, Ebdrup BH, Lindschou J, Gluud C, Glenth\u00f8j BY. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users (Protocol). Cochrane Database of Systematic Reviews. 2015; (1).17. Art. No.: CD011481. DOI: 10.1002\/14651858.CD011481 .","DOI":"10.1002\/14651858.CD011481"},{"issue":"4","key":"90_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/1355621021000005973","volume":"7","author":"G Gerra","year":"2002","unstructured":"Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol. 2002;7(4):385\u201395. doi: 10.1080\/1355621021000005973 .","journal-title":"Addict Biol"},{"issue":"3","key":"90_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.psychres.2012.02.008","volume":"198","author":"G Quaglio","year":"2012","unstructured":"Quaglio G, Pattaro C, Gerra G, Mathewson S, Verbanck P, Des Jarlais DC, et al. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam. Psychiatry Res. 2012;198(3):457\u201362.","journal-title":"Psychiatry Res"},{"issue":"2","key":"90_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12023","volume":"77","author":"SD Hood","year":"2014","unstructured":"Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK. Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol. 2014;77(2):285\u201394.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"90_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/0023210-200923010-00002","volume":"23","author":"M Lader","year":"2009","unstructured":"Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009;23(1):19\u201334. doi:2312 [pii].","journal-title":"CNS Drugs"},{"issue":"1","key":"90_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","volume":"104","author":"JM Parr","year":"2009","unstructured":"Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Mc DYR. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction (Abingdon, England). 2009;104(1):13\u201324.","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"90_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1360-0443.2008.02402.x","volume":"104","author":"M Lader","year":"2009","unstructured":"Lader M. Coming off tranquillizers: a Sisyphean toil. Addiction (Abingdon, England). 2009;104(1):25\u20136. doi: 10.1111\/j.1360-0443.2008.02402.x .","journal-title":"Addiction (Abingdon, England)"},{"issue":"7","key":"90_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/070674370605100706","volume":"51","author":"RC Voshaar","year":"2006","unstructured":"Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH, et al. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatr. 2006;51(7):445\u201352.","journal-title":"Can J Psychiatr"},{"issue":"1","key":"90_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12888-015-0493-y","volume":"15","author":"M Liebrenz","year":"2015","unstructured":"Liebrenz M, Gehring M-T, Buadze A, Caflisch C. High-dose benzodiazepine dependence: a qualitative study of patients\u2019 perception on cessation and withdrawal. BMC Psychiatry. 2015;15(1):116.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"90_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/713659419","volume":"19","author":"W Wickes","year":"2000","unstructured":"Wickes W, Darke S, Ross J. Clobazam maintenance among methadone maintenance patients with problematic benzodiazepine use: five case studies. Drug Alcohol Review. 2000;19(4):5.","journal-title":"Drug Alcohol Review"},{"key":"90_CR16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","volume":"193","author":"VP Dole","year":"1965","unstructured":"Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. 1965;193:646\u201350.","journal-title":"JAMA"},{"issue":"9148","key":"90_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221\u20136. doi: 10.1016\/S0140-6736(98)05356-2 .","journal-title":"Lancet"},{"issue":"1","key":"90_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2008.07.001","volume":"20","author":"RG Newman","year":"2009","unstructured":"Newman RG. \u201cMaintenance\u201d treatment of addiction: to whose credit, and why it matters. Int J Drug Policy. 2009;20(1):1\u20133. doi: 10.1016\/j.drugpo.2008.07.001 .","journal-title":"Int J Drug Policy"},{"issue":"3","key":"90_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/026988110401800321","volume":"18","author":"AR Lingford-Hughes","year":"2004","unstructured":"Lingford-Hughes AR, Welch S, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2004;18(3):293\u2013335. doi: 10.1177\/026988110401800321 .","journal-title":"J Psychopharmacol"},{"issue":"4","key":"90_CR20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1440-1614.2003.01211.x","volume":"37","author":"T Weizman","year":"2003","unstructured":"Weizman T, Gelkopf M, Melamed Y, Adelson M, Bleich A. Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity. Aust N Z J Psychiatry. 2003;37(4):458\u201363.","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"11","key":"90_CR21","doi-asserted-by":"crossref","first-page":"e0142057","DOI":"10.1371\/journal.pone.0142057","volume":"10","author":"M Liebrenz","year":"2015","unstructured":"Liebrenz M, Schneider M, Buadze A, Gehring MT, Dube A, Caflisch C. High-dose benzodiazepine dependence: a qualitative study of patients\u2019 perceptions on initiation, reasons for use, and obtainment. PLoS One. 2015;10(11):e0142057. doi: 10.1371\/journal.pone.0142057 .","journal-title":"PLoS One"},{"issue":"7","key":"90_CR22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0277-9536(00)00210-0","volume":"52","author":"LM Noble","year":"2001","unstructured":"Noble LM, Douglas BC, Newman SP. What do patients expect of psychiatric services? A systematic and critical review of empirical studies. Soc Sci Med. 2001;52(7):985\u201398.","journal-title":"Soc Sci Med"},{"issue":"1","key":"90_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000289028","volume":"65","author":"DN Clinton","year":"1996","unstructured":"Clinton DN. Why do eating disorder patients drop out? Psychother Psychosom. 1996;65(1):29\u201335.","journal-title":"Psychother Psychosom"},{"issue":"14","key":"90_CR24","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3109\/10826089909039442","volume":"34","author":"S Koester","year":"1999","unstructured":"Koester S, Anderson K, Hoffer L. Active heroin injectors\u2019 perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction? Substance Use & Misuse. 1999;34(14):2135\u201353.","journal-title":"Substance Use & Misuse"},{"key":"90_CR25","first-page":"107","volume":"5","author":"HN Higginbotham","year":"1977","unstructured":"Higginbotham HN. Culture and the role of client expectancy. Topics in Culture Learning. 1977;5:107\u201324.","journal-title":"Topics in Culture Learning"},{"issue":"7164","key":"90_CR26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/bmj.317.7164.963","volume":"317","author":"N Britten","year":"1998","unstructured":"Britten N. Psychiatry, stigma, and resistance. Psychiatrists need to concentrate on understanding, not simply compliance. BMJ. 1998;317(7164):963\u20134.","journal-title":"BMJ"},{"key":"90_CR27","series-title":"Forum qualitative sozialforschung\/forum: qualitative social research","volume-title":"Qualitative content analysis","year":"2000","unstructured":"Mayring P, editor. Qualitative content analysis, Forum qualitative sozialforschung\/forum: qualitative social research. 2000."},{"key":"90_CR28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-3-531-92052-8_42","volume-title":"Qualitative inhaltsanalyse. Handbuch qualitative Forschung in der Psychologie","author":"P Mayring","year":"2010","unstructured":"Mayring P. Qualitative inhaltsanalyse. Handbuch qualitative Forschung in der Psychologie. Wiesbaden: Springer; 2010. 601\u201313."},{"key":"90_CR29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-244X-11-90","volume":"11","author":"KW Chen","year":"2011","unstructured":"Chen KW, Berger CC, Forde DP, D\u2019Adamo C, Weintraub E, Gandhi D. Benzodiazepine use and misuse among patients in a methadone program. BMC Psychiatry. 2011;11:90. doi: 10.1186\/1471-244X-11-90 .","journal-title":"BMC Psychiatry"},{"issue":"7","key":"90_CR30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/gme.0b013e31825a28f2","volume":"19","author":"WE Reichman","year":"2012","unstructured":"Reichman WE, Rose NS. History and experience: the direction of Alzheimer\u2019s disease. Menopause. 2012;19(7):724\u201334. doi: 10.1097\/gme.0b013e31825a28f2 .","journal-title":"Menopause"},{"issue":"2","key":"90_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/ebmed-2014-110117","volume":"20","author":"PB Rosenberg","year":"2015","unstructured":"Rosenberg PB. Benzodiazepine exposure increases risk of Alzheimer\u2019s disease. Evid Based Med. 2015;20(2):75. doi: 10.1136\/ebmed-2014-110117 .","journal-title":"Evid. Based Med."},{"key":"90_CR32","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"SB Gage de","year":"2014","unstructured":"de Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, et al. Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ. 2014;349:g5205.","journal-title":"BMJ"},{"issue":"5","key":"90_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/14740338.2015.1014796","volume":"14","author":"S Billioti de Gage","year":"2015","unstructured":"Billioti de Gage S, Pariente A, B\u00e9gaud B. Is there really a link between benzodiazepine use and the risk of dementia? Expert Opin Drug Saf. 2015;14(5):733\u201347.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"90_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/wps.20219","volume":"14","author":"R Balon","year":"2015","unstructured":"Balon R, Fava GA, Rickels K. Need for a realistic appraisal of benzodiazepines. World Psychiatry. 2015;14(2):243\u20134.","journal-title":"World Psychiatry"},{"issue":"11","key":"90_CR35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1586\/14737175.2014.963057","volume":"14","author":"V Starcevic","year":"2014","unstructured":"Starcevic V. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Expert Rev Neurother. 2014;14(11):1275\u201386.","journal-title":"Expert Rev Neurother"},{"issue":"03","key":"90_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-0030-1262817","volume":"11","author":"M Liebrenz","year":"2010","unstructured":"Liebrenz M, Stohler R, Caflisch C. Benzodiazepine dependence on agonist therapy (DSM-IV)\u2014evidences and own results. Suchttherapie. 2010;11(03):112\u20135.","journal-title":"Suchttherapie"},{"issue":"11","key":"90_CR37","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","volume":"28","author":"M Peyrot","year":"2005","unstructured":"Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"90_CR38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archinte.163.6.681","volume":"163","author":"BM Egan","year":"2003","unstructured":"Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163(6):681\u20137.","journal-title":"Arch Intern Med"},{"key":"90_CR39","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;6(2):CD002207. doi: 10.1002\/14651858.CD002207.pub4 .","DOI":"10.1002\/14651858.CD002207.pub4"},{"issue":"9525","key":"90_CR40","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","volume":"367","author":"C Nordt","year":"2006","unstructured":"Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet. 2006;367(9525):1830\u20134. doi: 10.1016\/S0140-6736(06)68804-1 .","journal-title":"Lancet"},{"issue":"9","key":"90_CR41","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","volume":"103","author":"P Lawrinson","year":"2008","unstructured":"Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS. Addiction. 2008;103(9):1484\u201392. doi: 10.1111\/j.1360-0443.2008.02249.x .","journal-title":"Addiction"},{"issue":"1","key":"90_CR42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O\u201a\u00c4\u00f4Grady KE, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programmes? Int J Drug Policy. 2010;21(1):36\u201342. %@ 0955\u20133959.","journal-title":"Int. J. Drug Policy"},{"issue":"1\u20132","key":"90_CR43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","volume":"104","author":"SY Fang","year":"2009","unstructured":"Fang SY, Chen CY, Chang IS, Wu EC, Chang CM, Lin KM. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend. 2009;104(1\u20132):140\u20136. doi: 10.1016\/j.drugalcdep.2009.04.017 .","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 2","key":"90_CR44","first-page":"21","volume":"66","author":"JC Stevens","year":"2005","unstructured":"Stevens JC, Pollack MH. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005;66 Suppl 2:21\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"90_CR45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1\u20132):8\u201318. doi: 10.1016\/j.drugalcdep.2012.07.004 .","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-015-0090-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:16:11Z","timestamp":1498259771000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.harmreductionjournal.com\/content\/13\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1186\/s12954-015-0090-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]},"article-number":"1"}}